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ABSTRACT 
Generally, the most challenging problems in cancer are extreme malignancy and 
resistance to chemotherapy. Thus, it is very important to detect new targets with 
related to tumor progress mechanism for improving gene therapy. Recent studies 
indicate that N-Myc downstream regulated gene 2(NDRG2), is highly suppressed in a 
lot of cancer types. Previous study shows that NDRG2 have an in vivo interaction with 
Antiapoptotic protein 5(API5) by using yeast-2-hybrid screen for mouse brain cDNA 
library. API5 regulation by NDRG2 might reduce survival ability of tumor cells and it 
might sensitize the tumor cells against chemotherapeutic treatments. This interaction 
might be the key of E2F1-dependent apoptosis and Acinus-mediated DNA 
fragmentation. The interaction between the NDRG2 and API5 are examined with GST 
pull down assay in vitro besides, in order to discover importance of leucine zipper 
domain of API5, NDRG2 also tested with truncated API5 versions. The results indicate 
a slight regulation of API5 by NDRG2 but truncated versions of API5 do not interact 
with NDRG2. Our findings support but not prove that NDRG2 might be a down 
regulator of API5 in tumor cells.           
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INTRODUCTION 
Theory and Recent Studies 
 
In this project, we try to exhibit a physical  interaction between NDRG2 and API5 
proteins. N-myc down regulated gene 2 (NDRG2) is one of the member of NDRG 
protein family, which includes 4 members. NDRG2 composes from 357 amino acids 
and it approximately is 40 kDa. It is widely expressed in brain, heart, skeletal muscle 
and kidney. As a protein, NDRG2 is localized in cytosol and it has alpha/beta 
hydrolase fold structure. Human NDRG2 shows 57% similarity to NDRG1 and NDRG3, 
%61 similarity to NDRG4-H, %63 similarity to NDRG4-Bvar, %65 similarity to NDRG4-B 
and %92 similarity to mouse NDRG2 respectively, based on amino acid level [4]. 
 
 
Human NDRG2 is located at chromosome 14q11., and it is involved in a lot of cellular 
mechanism, especially in the cell differentiation and proliferation [1]. NDRG2 is 
associated with glioblastoma U373 cell proliferation, it is highly suppressed in 
glioblastoma cells and overexpression of NDRG2 significantly represses cell 
proliferation [2]. Furthermore, NDRG2 level is reduced in gastric cancers and liver 
cancers but it is upregulated in alzheimer disease [4].  The pathway of cell 
proliferation by NDRG2 is unknown but a novel research exhibits an interaction 
between 58kDa-microspherule protein MSP58 (MSCR1) and NDRG2. MSP58 as a 
nuclear protein might translocate the cytoplasmic protein NDRG2 in to the nucleus, 
this interaction might be the key of the NDRG2 dependent proliferation [3]. In tumor 
cell lines, NDRG2 level is significantly upregulated. Besides, while suppressing of 
NDRG2 inhibits the apoptosis, overexpression of NDRG2 increases the apoptosis in 
A549 cells (adenocarcinomic human alveolar basal epithelial cell) [5]. 
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Previous study exhibits an interaction between NDRG2 protein with Apoptosis 
inhibitor 5 protein (API 5; AAC-11) in vivo by using yeast-2-hybrid method [11]. 
Therefore, our idea is NDRG2 might interact with API 5 to regulate cell apoptosis 
mechanism.  
 API5 gene is located at 11p11.2 and it is conserved in chimpanzee, dog, cow, mouse, 
rat, chicken, zebrafish, fruit fly, mosquito, A.thaliana, and rice. Human API5 has 4 
isoforms, size of the long version of API5 is 510 amino acids and 57561Da, its located 
mostly in nucleus but API5 isoform 3 is located in cytoplasm [6]. In addition, API5 has 
a leucine zipper domain between 370-391amino acid sequences [11]. 
 
 
API5 as a protein inhibits apoptosis by preventing acinus-mediated DNA 
fragmentation. API5 protein physically interacts with acinus and prevents its cellular 
function through protecting the acinus from caspase-3 cleavage. API5 has a leucine-
zipper domain, which is not interacting with DNA; it interacts with acinus at 
oligomerization stage and forms an API5-acinus complex [7]. Acinus is cut into small 
fragments by caspase in order to produce an active molecule (p17) through the 
apoptosis progress [9]. Recent data shows that p17 is necessary for chromatin 
condensation and API5 prevents formation of p17 fragment by binding to a domain of 
acinus(residues 840-918), that is very close to the caspase cleavage  region(987-
1093). Therefore, API5 might prevent acinus cleavage by preventing to access of 
caspase to active site of acinus or API5-acinus complex might changes the 
conformation of acinus and this could makes inaccessible the active site for 
interaction with caspase. New evidences shows that, silencing of Acinus does not 
interfere apoptotic chromatin condensation, actually a little bit accelerates it. On the 
other side, DNA fragmentation is blocked by Acinus silencing, which indicates Acinus 
is necessary for DNA fragmentation but not for chromatin condensation [10].  
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Figure 1. NDRG2 might supress API5 dependent cell survival by preventıng E2F-dependent cell 
apoptosis and Acınus-mediated DNA fragmentation[previous studies, M. Cathy] . 
 
Recent studies show that E2 promoter binding factor 1-dependent apoptosis might 
suppressed by API5 in particularly tumor cells. The results exhibit that API5 may help 
to surviving of tumor cells by preventing E2F1-induced cell death, especially when 
cells exposed to negative conditions. API5 affects downstream of E2F and represses 
apoptosis mechanism of E2F without repressing E2F induced transcription. 
Furthermore, depletion of API5 is lethal for tumor cells [8]. 
 
According to all these information our theory takes a form as illustrated in figure 1. 
Therefore, we assume that NDRG2 leading cells to apoptosis by preventing API5 
induced apoptosis suppression.  
pGEX-6P2  and pGEX-NDRG2L Plasmids       
 
pGEX-6P2 plasmid is around 4985bp and shows high expression with IPTG induction.  
It includes plenty of restriction sites, Ampicillin resistant gene for Bacteria and GST 
(Glutathione S-Trensferase ) tag [12]. Laclq is a region which allows over production 
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of lac repressor protein and can be induced by IPTG. It helps to control 
expression[13], see Figure 2.   
 
Figure 2. Plasmid pGEX-6P2 is around 4985bp. GST presents GST(Glutathione S-Transferase) tag, 
AmpR shows Ampicillin resistance gene,  Ori is Origin of Replication [12]. Laclq is a mutation which 
allow high lac operator repressor protein production [13]. 
          
 
MCRS1 and API5 Plasmids 
 
Y4 plasmids including MCRS1 fragment is around 9559bp.  Y2 plasmid including API5 
fragment is around 11628bp, see Figure 2. 
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    a)    b)  
Figure 2. Templates for PCR reaction. a)Y4 plasmid for MCRS1 fragment. b) Y2 plasmid for 
truncated version of API5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
MATERIALS AND METHODS 
 
Recombinant Protein Expression: GST and GST-NDRG2L proteins 
a. Plasmid preparation from pGEX-6P2 and pGEX-NDRG2L   
b. Restriction analysis to check plasmids 
c. Transformation into BL21 StarTM(DE3) One Shot® Cells 
d. IPTG induction 
e. SDS-PAGE and Western Blotting  to check proteins 
Plasmid Cloning: MCRS1, truncated versions of API5  
a. PCR reactions  
b. Checking bands on agarose gel and purification of PCR products 
c. Restriction digestion and purification of bands from agarose gel 
d. Ligation of vector with MCRS1 or truncated versions of API5  
e. Transformation into DH5α Cells and plating on LB-agar plates 
f. Plasmid isolation and restriction analysis to check plasmids on agarose gel 
g. Sequncing plasmids with CMV forvard and BGH reverse primers 
In vitro Protein Binding Assay: NDRG2L protein with MCRS1 and API5 proteins    
a. Synthesis of prey proteins and Western Blotting 
b. Immobilization of GST proteins and Western Blotting 
c. Pull down assay and Western Blotting 
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Recombinant Protein Expression: GST 
and GST-NDRG2L proteins 
Plasmid preparation from pGEX-6P2 and pGEX-NDRG2L 
 
Two cultures which including either pGEX-6P2 or pGEX-NDRG2L plasmids are 
harvested as old cultures and another culture including pGEX-NDRG2L plasmid are 
harvested as a new culture. Their plasmids are prepared by Genelute Plasmid 
Miniprep Kit, see Appendix I.  
Restriction Analysis to Check Plasmids 
 
Restriction analysis are done for both pGEX-NDRG2L old sample plasmids and new 
sample plasmids by using either NcoI or EcoRV (BioLab) restriction enzymes. Buffer 3 
is used for NcoI and Buffer 3+ BSA for EcoRV, see Table 1. Samples are incubated at 
37C for 1,5h.  
 
Table 1. Restriction analysis procedure 
NcoI EcoRV 
DNA 5µl DNA 5µl 
Buffer (3) 2µl Buffer (3+BSA) 2µl 
NcoI 1µl EcoRV 1µl 
H2O 12µl H2O 12µl 
Total 20µl Total 20µl 
 
Bands are checked on %1 agarose gel. 
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Transformation into BL21 StarTM(DE3) One Shot® Cells 
 
Plasmids are transformed into into BL21 StarTM(DE3) One Shot® Cells. Cultures are 
grown at 37C overnight, see Appendix II. 
IPTG induction 
 
Cultures including pGEX-6P2 and pGEX-NDRG2L (old cultures) and cultures including 
pGEX-NDRG2L (new culture) are induced with IPTG. Induction is applied for 6h for old 
cultures, for 2h and overnight for new culture, see Appendix III. Their 2ml. amount of 
new culture samples are taken to lyse by sonication method, see Appendix IV; all of 
old culture samples is used for French Press, see Appendix V. Lysis buffer which is 
used in sonication and French Press is prepared, see Appendix VI.   
SDS-PAGE and Western Blotting  to Check Proteins 
 
SDS-PAGE is applied for 0h and 6h IPTG inducted old samples consist of pGEX-6P2 and 
pGEX-NDRG2L plasmids, see Appendix VII. %12 Tris-Glycine SDS-PAGE is used along 
PageRulerTM Prestained Protein Ladder.  
Western Blotting is applied for samples after lysis of cells as mentioned below, see 
Table 2. %12 Bis-Tris SDS-PAGE (Invitrogen) is used for SDS-PAGE and PageRulerTM 
Prestained Protein Ladder is used as a marker. Anti-GST goat antibody is used as 
primary antibody, Anti-goat antibody is used as secondary antibody, see Appendix 
VIII.    
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        Table 2. Samples that are used in Western Blotting 
Samples  Dilution Factor 
pGEX-6P2 supernatant 6h  1:10 
pGEX-NDRG2L supernatant 6h 1:1 
pGEX-NDRG2L supernatant 0h 1:1 
pGEX-NDRG2L supernatant 2h 1:1 
pGEX-NDRG2L supernatant O/N 1:1 
pGEX-NDRG2L total cell lysate 0h 1:1 
pGEX-NDRG2L total cell lysate 2h 1:1 
pGEX-NDRG2L total cell lysate O/N 1:1 
 
SDS-PAGE is applied with 10µl sample except first one (1µl sample+ 9µl lysis buffer). 
Sample and sample buffer are heated 95C for 5min before loaded. 
Western Blot results are observed in dark room. 
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Plasmid Cloning: MCRS1, truncated 
versions of API5 
PCR Reactions  
 
PCR reactions are carried out to obtain MCRS1 and truncated versions of API5, see 
Appendix IX. Template for MCRS1 is Y4 and template for API5s is Y2. 
In order to amplify intended regions, spesific primers are used to obtain expected 
sizes, see Table 3.  
Table 3. PCR reactions 
Fragment 
Name 
Primer Forward Primer 
Reverse 
Template Size(Restriction 
enzmyes) 
MCRS1 5’ pACT2 3’ AD-Xba Y4 1.6kb (NotI/XbaI) 
N-293 NS-293F XX-524R Y2 800bp (NotI/XbaI) 
C-369 5’ pACT2 XX-369R Y2 1.1kb(NotI/XbaI) 
C-400 5’ pACT2 XX-400R Y2 1.2kb (NotI/XbaI) 
 
Primer sequences are shown below; mutated sites are in italics, restriction enzyme 
sites are underlined, see Table 4. 
 
Table 4. Primer sequences with their length 
Primer Sequences (5’-3’) Length 
5’ pACT2 CGATGATGAAGATACCCCAC 20 
3’ AD-Xba GACTCTAGATGGTGCACGATGCACAG 26 
NS-293F GGAGCGGCCGCGTCGACATGAGTTCATTTTGTGGTG 36 
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XX-524R GACTCTAGAAGCTCGAGACAATGCTGAAGAATG 33 
XX-369R CCATCTAGACTCGAGCCTTCTATTTTTCTGCATTCAGTTTG 41 
XX-400R CCATCTAGACTCGAGGCCTAGCCTGTTTTACCCTG 35 
Checking Bands on Agarose Gel and Purification of PCR Products 
 
PCR products are ckecked on %1 agarose gel. After checking bands, PCR products are 
purified with High Pure PCR Product Purification Spin Column Kit, see Appendix X.  
 
Restriction Digestion and Purification of Bands from Agarose Gel 
 
PCR products are digested by NotI and XbaI restriction enzymes and with other 
substances which are shown below, see Table 5. They are incubated at 37C for 1.5 
hours. 
Table 5. Restriction analysis procedure by enzymes NotI and XbaI (amounts for per tube) 
NotI 0.5µl 
XbaI 0.5µl 
Buffer 3+BSA 2µl 
H2O 12µl 
Template DNA 5µl 
 
Furthermore, pcDNA6-HA2-Y2 vector is also digested by NotI and XbaI enymes which 
is used to clone fragments inside, see Figure 4.  
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Figure 4. pcDNA6-HA2-Y2 vector and restriction enzyme sites and other regions. 
All fragments and vector is checked on %1 agarose gel. Then, they are run on %0.7 
agarosel gel. Bands are purified from gel, see Appendix XI.  
Ligation of Vector with MCRS1 or Truncated Versions of API5 
 
MCRS1 and truncated versions of API5 fragments are ligated with pcDNA-HA2-Y2 
vector, see Appendix XII.  
Transformation into DH5α Cells and Plating on LB-Agar Plates 
 
Ligated plasmids are transformed into DH5α cells, see Appendix XIII. After 
transofmation, they are plated on LB-agar plates as 100µl and rest of sample and 
grown overnight. Then, they are picked up as 30 colonies for all different plasmids. 
MCRS1 100µl/1,2,3,4,5,6,7 and rest/2,3,4  
API5-N293 100µl/1,2,3,4 and rest/1,2,3,4  
API5-C369 100µl/1,2,3,4 and rest/1,2  
API5-C400 100µl/1,2,3,4 and rest/1,2  
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Plasmid Isolation and Restriction Analysis to Check Plasmids on 
Agarose Gel 
 
30 colonies are grown to isolate plasmids, see Appendix I. Restriction analysis is done 
by NotI and XbaI. Mixture shown as below is incubated at 37C for 1.5 hours , see 
Table 6. They are run on %1 agarose gel. 
Table 6. Restriction analysis for 32 colonies by using enzymes NotI and XbaI 
 Ligated Plasmid (µl) Negative Control(µl) 
DNA 4 - 
Buffer (10x) 3+ BSA 2 2 
H20 13 17 
NotI 0.5 0.5 
XbaI 0.5 0.5 
Total 20 20 
 
Sequncing Plasmids with CMV Forvard and BGH Reverse Primers 
 
Plasmids are chosen from agarose gel with best results from each and sequenced.  
Sequencing is applied with CMV forward primer and BGH reverse primer, see 
Appendix XIV. Samples are purified after sequence reaction, see Appendix XV. 
Sequencing machine is used to analyse results.  
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In Vitro Protein Binding Assay: NDRG2L 
protein with MCRS1 and API5 Proteins 
Phase 1: Synthesis of prey protein and Western Blotting 
 
Prey proteins; ;  pcDNA6-HA2 (negative control), MCRS1, API5, API5-N293, API5-C369 
and API5-C400 are transcripted and translated with using TNT T7 quick master mix 
with regard to Appendix XVI. Afterwards, 6 prey samples loaded on SDS-PAGE gel in 
order to carry on western blotting by following Appendix VIII. 
 
Phase 2: Immobilization of GST Proteins and Western Blotting 
 
Phase 2 is carried on with using 6h samples of GST and GST-NDRG2 proteins from 
French press with regard to protocol of phase 2, see Appendix XVII. Western blotting 
is applied first with GST antibody, second with NDRG2 antibody. 
 
Phase 3: Pull-Down assay and Western Blotting 
 
Phase 3 is executed regard to the protocol, see Appendix XVIII. After western blotting, 
panceau red dye is used for checking protein presence on membrane.  
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RESULTS 
 
Recombinant Protein Expression: GST and GST-NDRG2L proteins 
 
pGEX-6P2 and pGEX-NDRG2L  plasmids were isolated from cultures. Restriction 
analysis was done by EcoRV or NcoI for old/new plasmids of pGEX-NDRG2L, see 
Figure dd.   
 
 
 
 
Figure 5. Agarose gel electrophoresis to check pGEX-NDRG2L after digestion with EcoRV or NcoI. 
First line shows 1 Kb Marker.   
 
As it is shown in Figure 5, new plasmids have the best results. Especially, digestion 
with EcoRV shows three clear bands, which first one between 3000-4000bp, second 
one around 2000bp and third one is around 400bp.   
 
After transformation of pGEX-6P2 and pGEX-NDRG2L plasmids into BL21 StarTM(DE3) 
One Shot® Cells, cultures were induced with IPTG 6h for old cultures or 2h and 
overnight for new cultures of pGEX-NDRG2L. Induced cells are lysed with sonication 
p
G
EX
-N
D
R
G
2
L 
n
ew
 /
Ec
o
R
V
  
p
G
EX
-N
D
R
G
2
L 
 
n
ew
/N
co
I 
   p
G
EX
-N
D
R
G
2
L 
o
ld
 /
Ec
o
R
V
 
 p
G
EX
-N
D
R
G
2
L 
o
ld
 /
N
co
I 
 
5000bp 
4000bp 
3000bp 
 
2000bp 
 
 
 
 
 
 
 
400bp 
20 
 
for SDS-PAGE analysis and French Press method to go further in the experiment. SDS-
PAGE results are indicated in Figure 6, which shows proteins of old cultures including 
pGEX-6P2 or pGEX-NDRG2L after and before IPTG induction for 6h. 
 
 
 
 
 
Figure 6. SDS-PAGE results for old cultures of pGEX-6P2 and pGEX-NDRG2L. First line shows protein 
ladder. Second and forth lines are 0h and 6h pGEX-6P2 plasmid proteins; third and fifth lines are 0h 
and 6h pGEX-NDRG2L plasmid proteins.  
 
According to SDS-PAGE results, 0h samples have bands less than 10 kDA. 6h samples 
have more strong bands. Plasmid pGEX-6P2 has a high expression around 25kDa for 
6h induction.  
 
New plasmids which is including pGEX-NDRG2L plasmid were prepared as 
supernatant and lysate for Western Blotting. Also, supernatants of 6h inducted old 
samples of pGEX-6P2 and pGEX-NDRG2L were analysed in this method. Figure 7 
illustrates results for proteins with antibodies.  
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Figure 7. Western Blot results of cultures. First and seventh lines are protein ladder; second and 
third lines are 6h induced old cultures’ supernatant of pGEX-6P2 and pGEX-NDRG2L. The other 
lines show new culture proteins as supernatants 0h, 2h, O/N and lysate 0h,2h, O/N. 
 
Western blot analysis shows that old culture supernatant of pGEX-6P2 has some 
strong bands and around 25kDa,  higher than 70kDa and less than 10kDa. Old culture 
supernatant of pGEX-NDRG2L has several bands and a strong band around 70kDa.  
 
New culture supernatant induced for 0h and lyste induced for 0h and 2h of pGEX-
NDRG2L have not any spesific bands. On the other hand, new culture pGEX-NDRG2L 
supernatant for induced for 2h has a band around 70kDa. Both supernatant and 
lysate of overnight induced culture of pGEX-NDRG2L has many bands around 70kDa, 
35kDa and 25kDa. 
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Plasmid Cloning: MCRS1, truncated versions of API5 
 
MCRS1 and truncated versions of API5 were amplified and PCR products were 
checked on agarosel gel, see Figure 8. 
 
 
 
Figure 8. PCR products of MCRS1, API5-N293, API5-C369 and API5-C400. First and last lines are 
marker.  
 
After checking bands, fragments and vector were digested with NotI and XbaI and run 
on agarose gel. Figure 9 shows fragments. 
 
 
 
Figure 9. Restriction enzyme analysis results. It shows in the order Marker, vector, MCRS1, API5-
N293, API5-C369 and API5-C400 and Marker. 
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After restriction analysis, fragments were run on agarose gel and purified from gel. 
Vector and fragments were ligated. Plasmids were transformed into DH5α cells and 
colonies were picked up from grown cultures on plates. Their plasmids were isolated 
from 30 colonies. Restriction analysis was applied by NotI and XbaI to check plasmids 
on agarose gel is shown in Figure 10. 
                          
Figure 10. Restriction analysis after ligation. First part (left on the top between markers) shows 
vector and MCRS1 fragments. Second part (right on the top) shows vector and API5-N293 
fragments. Third part (left on the bottom) shows vector and API5-C369 fragments. Last part (right 
on the bottom) shows vector and API5-C400 fragments. 
 
According to restriction enzyme digestion results, colonies MCRS1 100µl/3, API5-
N293 rest/1, API5-C369 rest/2 and API5-C400 rest/1 were picked to sequence analysis 
and go further. Sequence analysis are proved that sequences are correlated with 
original sequences (Results have not been shown in here).   
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In Vitro Protein Binding Assay: NDRG2L protein with MCRS1 and API5 
Proteins 
 
Prey proteins;  pcDNA6-HA2 (negative control), MCRS1, API5, API5-N293, API5-C369 
and API5-C400 were expressed in vitro. Western Blot results are shown in Figure 11.  
 
 
 
 
Figure 11. Western Blot results of prey proteins. In the order; protein ladder, pcDNA6-HA, MCRS1, 
API5, API5-N293, API5-C369 and API5-C400 
 
Western blot results show that negative control has no spesific bands. MCRS1 and 
API5 lines has one band on the top of gel. API5-N293 line has a band around 35kDa, 
API5-C369 line has a band around 40kDa and API5-C400 line has a band around 
45kDa. 
 
Immobilization of GST proteins were carried out by using cell lysate of cultures 
including GST or GST-NDRG2L plasmids and Western blot results are shown in Figure 
12.  
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Figure 12. Western blot results of GST proteins with GST antibody. First line shows marker, second 
line shows GST and third line shows GST-NDRG2L.   
 
In Figure,  It shows that GST has two bands and GST-NDRG2L has several bands. 
This phase was repeated with NDRG2 antibody. Western Blot results are shown in 
Figure 13.  
 
 
 
Figure 13. Western Blot results of GST proteins with NDRG2 antibody. First line shows marker, 
second line shows GST and third line shows GST-NDRG2L. 
According to western blot result, GST has no bands, whether GST-NDRG2L has some 
bands. 
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Pull down assay is applied and Western Blot results is shown in Figure 14.  
 
 
 
 
                                            
Figure 14. Western blot results of pull down assay. Fragment (MCRS1, API5, API5-N293 and API5-
C369) with GST in the first four lines after marker and with NDRG2L in the last four lines. 
 
In figure 14, only NDRG2L+API5 has a band around 70kDa.  
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DISCUSSION 
The initial hypotesis was that NDRG2 is a mediator for E2F1-dependent apoptosis and 
Acinus-mediated DNA fragmentation by interacting with API5 protein. The data 
shows that, NDRG2 have a slight interaction with API5 protein in vitro.  
The experiment designed to discover whether NDRG2 protein regulate API5 protein 
and whether check out leucine zipper domain of API5 responsible for this interaction 
between API5 and NDRG2. For this reason, leucine zipper domain was examined 
through creating truncated versions of API5 and results shows that all API5 products 
successfully obtained.  
First truncated API5 product; N293 (API5) was design to check out first 293 amino 
acids is not important to NDRG2 interaction because it would still has the leucine 
zipper domain. After phase 1, translated N293 would be approximately 25 kDa, which 
is very close the western blotting data of phase 1 in Figure 11.  
Second truncated API5 product; C369 (API5) was design to discover importance of 
leucine zipper domain of API5, because of missing of leucine zipper domain; we 
expected to see no interaction with NDRG2. According to Figure 11, C369 is 
approximately 40 kDa, this data is very close to expected weight, also there is some 
week bands around 25kDa and 55kDa that might be diffusion error of gel membrane 
because all unexpected bands on the lanes are complementary with each other. 
Last truncated API5 product; C400 was design to show leucine zipper domain of API5 
is responsible from NDRG2 interaction. Missing of NLS domain provide to compare of 
importance this domain due to N293 has it. Therefore, we expected to see protein 
interaction between NDRG2 and C400. According to figure 11, C400 is very close to 
44kDa that is expected weight for this protein. In the lane of C400, also there are 
week bands at 25kDa, 40kDa and 55kDa, which are probably product of diffusion on 
gel membrane.  
Moreover, we also used API5 without truncated to prove API5 has an interaction with 
NDRG2 in vitro. Since we know API5 have an interaction with NDRG2 in vivo by yeast-
2-hybrid system, we expected to see this interaction in vitro by MagneGST-Pull-
Down-Assay. According to figure 11, API5 seems like does not run along the lane but 
there is one clear band at the top of the lane. This result shows that, there is HA-
antibody specific protein in the membrane, but because of a problem, proteins stuck 
on the top of the SDS-PAGE gel. This problem might come from protein denaturation 
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failure or TNT T7 transcription and translation system obstructs for API5 gene or 
protein.  
Besides, since we already know MSP58 interacts with NDRG2, we used also MSP58 as 
a prey in MagneGST-Pull down assay in order to reference as a positive control [3]. 
According to figure 11, MSP58 might not run along the SDS-PAGE gel. However, there 
is HA-specific protein at the top of the lane of MSP58 on the membrane. Therefore, 
probably MSP58 share same problem with API5.  
 Finally, we used an empty plasmid (pcDNA6-HA2) as a prey in MagneGST-Pull down 
assay to represent a negative control that has not included any protein to interact 
with NDRG2 protein. According to figure 11, there is no band on the empty plasmid 
lane of membrane, which is exactly expected result as a negative control. 
Afterwards, GST and GST-NDRG2 proteins are tagged with magnetic beads as baits in 
phase 2. As illustrated in figure 12, there is a band around 25 kDa, which is very close 
to expected weight (26kDa) of GST protein. There is also one extra band around 65 
kDa, which might come from GST-NDRG2 protein by diffusing. Besides, figure 13, 
shows another western blotting image with using NDRG2 specific antibody and as 
expected, there is no band on the GST lane of membrane. As presented figure 12, 
there are a lot of bands observed including expected band of GST-NDRG2 protein. 
However, in figure 13, clearly most of those unexpected proteins are disappeared, 
except ~25kDa band (probably GST), ~ 40kDa band (probably NDRG2) and one band 
at the top of the lane (does not run). These bands are probably parts of GST-NDRG2 
fusion protein and this situation imply a problem about GST-NDRG2 protein stability 
which might triggered by SDS-PAGE.  
With regard to the results, we can conclude API5 is slightly regulated by NDRG2 in 
vitro. However, western blotting of phase 3 of MagneGST-Pull down assay is not 
accurate to say leucine zipper domain of API5 responsible from NDRG2 interaction. In 
this point, we might compare our test experiments, which are negative (pcDNA-HA2) 
and positive (MSP58) controls. However we did not use the negative control because 
of the experiment limits and positive control was enough to prove there is a problem 
in phase 3. As indicated in figure 14, there is no interaction between MSP58 and 
NDRG2 but it is a well-known protein, which interacts with NDRG2. This problem 
might base on phase 3 because western blotting results of phase 1 and phase 2 
indicate presence of preys and baits respectively. On the other hand, in phase 3, 
there are no proteins except API5-NDRG2 at the western blotting. Still, we observe 
very little amount of other expected proteins in SDS-PAGE, after a revision into 
amounts of loaded proteins in phase 3. Therefore, our idea is that the proteins might 
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still bind to the MagneGST particles after elution step at phase 3 and possibly 
because of that we could not observe fusion proteins clearly. 
Even the findings are not adequate to prove our hypothesis completely; it is worth to 
investigate more deeply. Experiment might revise to change some parameters such 
as instead of using western blotting following to phase 3, it might be wisely to use 
radioactive 35S methionin –labeled method in order to prevent protein detection 
problems.  
Overexpression of API5 increases tumor cell surviving hence, inhibition of API5 
protein might sensitize the tumor cells to chemotherapy. After all, slight regulation of 
API5 by NDRG2 might help to develop API5 target medicines to induce tumor cells to 
apoptosis. As a result, NDRG2-API5 interaction might have an important role for 
developing new treatments and improving patient health care standards.   
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Appendix I 
Genelute Plasmid Miniprep Kit 
 
1. a. Harvest and lyse bacteria 
b. Pellet cells from 2 ml. overnight culture 1 min. Discard supernatant.  
c. Resuspend cells in 200µl Resuspension Solution. Pipette up and down or vortex. 
d. Add 200µl of Lysis Solution. Invert gently to mix. Do not vortex. Do not allow to 
stand for more than 5 min. 
2. a. Prepare cleared lysate 
b. Add 350µl of Neutralization Solution. Invert 4-6 times to mix.  
c. Spin 10 min. to pellet debris. 
3. a. Bind plasmid DNA to column 
b. Prepare mini-spin column in a collection tube: Add 500µl Column Preparation  
c. Solution to column. Spin 30sec.-1 min. Discard flowthrough. 
4. a. Wash to remove contaminants 
b. Optional: Add 500µl Optional Wash Solution to column. Spin 30sec.- 1 min. Discard 
flowthrough. 
c. Add 750µl Wash Solution to column. Spin 30sec.-1min. Discard flowthrough. 
d. Spin 1-2 min. to dry column. 
5. a. Elute purified plasmid DNA 
b. Transfer column to new collection tube. 
c. Add 50µl elution solution.Wait 1min. Spin 1min. DNA is in collection tube. 
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Appendix II 
Transformation into BL21 StarTM(DE3) One Shot® Cells 
 
1. Thaw cells on ice, one vial of per transformation. 
2. Add 5-10 ng plasmid DNA (total volume 1 to 5µl) into each vial of BL21 StarTM(DE3) 
One Shot® Cells and mix by stirring gently with pipette tip. Do not mix by pipetting 
up and down.  
3. Incubate on ice for 30 minutes. 
4. Heat-shock the cells for 30 seconds at 42C without shaking.  
5. Immediately transfer the tubes on ice. 
6. Add 250µl of S.O.C. medium (room temperature). 
7. Close the cap of the tube tightly, place the tube horizontal (fix with tape)(for better 
aeration), and incubate at 37C for 30 minutes with shaking (200rpm). 
8. Add the entire transformation reaction to 10ml. of LB containing the appropriate 
antibiotic (and 1% glucose, if desired). 
9. Grow overnight at 37Cwith shaking. 
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Appendix III 
IPTG Induction 
 
1. The overnight culture is grown to an optical density (OD600)=5 or higher. 
2. 10ml. of of the overnight culture is transferred to 100ml. LB+AMP medium contained 
in a 500ml. flask. 
3. The OD600 of the cultures should be at least 0.45. If not, the cultures are grown until 
this is achieved but : Step 5-7 should be initiated within 1 hour after transfer of the 
overnight culture. 
4. The culture (with OD600 about 0.45-0.6) is equilibrated (cooled) for 20-30min to 25C. 
5. A zero (0h) sample of 2ml. culture is taken immediately before addition of IPTG. The 
0-sample is centrifuged 5min. at 12000g, and pellet is saced at -20C. 
6. IPTG is added to the cultures to give a final concentration of 0.1mM. 
7. The cultures are incubated at 25C with vigorous shaking 2h, 6h or overnight. 
8. The cultures are harvested by centrifugation at 4000rpm (GSA rotor) for 15min. at 4C. 
Note: Remember to note volume of the harvested culture. 
9. The cell pellet is stored at -20C.  
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Appendix IV 
Sonication 
 
1. Resuspend the cell pellet from 2ml. culture in 400µl lysisbuffer. 
2. The suspension is treated by ultrasonication 3-5 sec. 10 times with 1 min. interval.  
3. 10µl of lysate is taken for SDS-PAGE and Western Blotting. 
4. The lysate is centrifuged at 12000 g (4C) for 10 min. 
5. The supernatant is transferred to an eppendorf tube.  
6. The sample may  stored at -20C a few days before analysis. 
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Appendix V 
French Press 
 
1. The cell pellet is resuspended in lysis buffer: 1/20 volume lysis buffer per volume cell 
culture. Note: Not less than 20 ml. buffer. 
2. The resuspended cells are lyzed in a French Press two times and centrifuged at 20000 
rpm (GSA rotor) for 15min at 4C.  
3. The supernatant is taken to a new tube and saved at -20C. 
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Appendix VI 
Lysis Buffer 
 
 1 X PBS 
 5 mM EDTA 
 5 mM dithiothreitol (Keeps a high reduction-potential and prevents S-S bridges) 
 150µg/ml lysozyme (not necessary with the French Press) 
 10 % glycerol (prevents protein crystal formation + denaturation at freezing) 
 0.1% Triton X-100 (detergent, disrupt the cell lipid membrane) 
 0.1mM phenylmethylsulfonylfluoride (inhibitor of serine-proteases) 
 5 mM benzamidine (inhibitor of proteolysis) 
 50 mM ε-aminocaproic acid (inhibitor of proteolysis) 
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Appendix VII 
SDS-PAGE 
 
Sample  10µl 
Sample Buffer 5µl 
1. Mixture is waited at 95C for 5 min. 
2. Spin down shortly. 
3. Run on the gel 120V for 1.5 hours. 
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Appendix VIII 
Western Blot (Amersham) 
 
Transferring SDS-PAGE to Membrane 
Two layed blotting pads, filter paper, gel, membrane, filter and two layers of blotting paper 
are put in proper apparatus. It is run in transfer buffer at 25V for 1 hour. 
 
Membrane Process and Detection 
1. Incubate blot in 20ml. Blocking Buffer for 30min. 
2. Wash 2x 2min. in 10ml. Wash Buffer. 
3. Dilute primary antibody in Dilution Buffer (e.g. 5µl in 10ml. dilution buffer ).Incubate 
with blot at room temperature for 1 hour. 
4. Wash 2x 10min. in 10ml. Wash Buffer. 
5. Dilute secondary antibody 1:4000 as 2.5µl in 10ml. dilution buffer. Incubate with blot 
for 1 hour. 
6. Wash 4x10min in 10ml. Wash Buffer.  
7. Put membrane on a plastic surface. Mix each 1ml of dye for protein on western blot. 
Wait 5min. 
8. Take photograph. 
 
Wash Buffer:  1x PBS 
Blocking Buffer: 20ml. PBS + 1g. Blocker(Amersham, Final: %5). Prepare fresh. 
Dilution Buffer: 20ml. PBS + 0.5g Blocker (Amersham, Final: %5). Prepare fresh or can be 
stored at 4C overnight. 
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Appendix IX 
PCR Reaction 
 
Mixture of; 
 Amount (µl) 
Plasmid Template (10ng /µl) 2 
Forward Primer (10pmol/µl) 2 
Reverse Primer (10pmol/µl) 2 
Water 37.5 
10x Pfu Reaction Buffer (vortex before use) 5 
10mM dNTPs (put on ice) 1 
Pfu Ultra DNA Polymerase 0.5 
Total 50 
 
PCR programme; 
1 cycle          94°C 2min. 
30 cycles      94°C 30 sec., 56°C 30 sec. , 72°C 2 min. 
1 cycle          72°C 10min. 
1 cycle          4°C 
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Appendix X 
High Pure PCR Product Purification Spin Column 
 
The High Pure columns (from Roche Applied Science) have a maximum capacity of up to 25 
µg DNA. 
The binding buffer contains guanidine hydrochloride which is an irritant. Wear gloves and 
follow usual safety precautions when handling. 
1. Add 5 volumes of binding buffer to the PCR product and mix well. 
2. Place a High Pure spin column in a collection tube and pipette the sample into the 
column. 
3. Centrifuge 30 sec at 13 K 
4. Empty the collection tube and put the column back into the same tube 
5. Add 0.5 ml wash buffer to the column, centrifuge 30 sec at 13 K 
6. Empty the collection tube and put the column back into the same tube. Add 0.2 ml wash 
buffer to the column, centrifuge 30 sec at 13 K 
7. Place the column in a new 1.5 ml E-tube where the lid has been cut off and discard the 
collection tube 
8. To elute the DNA add 30 µl elution buffer to the center of surface of the column. Wait 5 
min. Centrifuge 30 sec at 13 K. Discard the column 
 
If the DNA is eluted in H2O it should be stored -20°C to avoid acid hydrolysis. 
 
Binding buffer:  3M guanidine-thiocyanate, 10 mM Tris-HCl pH 6.6, 5% EtOH 
Wash buffer:  20 mM NaCl, 2 mM Tris-HCl pH 7.5, 80% EtOH 
Elution buffer:  (TE) 10 mM Tris-HCl, 1 mM EDTA, pH 8.5 
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Appendix XI 
Purifying DNA Fragments From Agarose Gels with High Pure PCR 
Product Purification Kit 
 
1. Check weight of gel slices before start to procedure. It is applied by pre-weighing and 
re-weighing tubes. 
2.  Add 300µl Binding Buffer for every 100mg. agarose gel slice to the E-tube. 
3. Dissolve agarose gel in order to release the DNA. 
Vortex the E-tube 15-30 seconds to resuspend the gel slice in the Binding Buffer. 
Incubate the suspension for 10 min. at 56C. 
Vortex the tube briefly every 2-3 min. during incubation. 
4. After dissolving, add 150µl isopropanol for every 100mg. agarose gel slice to the 
tube. Vortex thoroughly. 
5. Insert one High Pure filter tube into one Collection tube. Pipette the entire contents 
of the E-tube into the upper reservoir of the filter tube. Caution: Do not exceed 700µl 
total volume. If mixture is >700µl, split the volume and use two seperate filter tubes 
for each portion. 
6. Centrifuge 30-60 seconds at max. speed in a standart table top centrifuge at 15-25C. 
7. Discard flow-through solution and reconnect filter tube with the same collection 
tube. 
8. Add 500µl Wash Buffer to the upper reservoir and centrifuge 1 minute at maximum 
speed. 
9. Discard the flow-through solution 
Combine filter tube with the same collection tube. 
Add 200µl Wash Buffer. 
Centrifuge 1 minute at maximum speed. 
10. Discard the flow-through solution and reconnect the filter tube to a new 1.5ml E-
tube. 
11. Add 30µl Elution Buffer and wait 5 min. Centrifuge 1 minute at maximum speed. 
12. E-tube contains the purified DNA. 
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Appendix XII 
Ligation 
 
Substances are mentioned as below are mixed and waited for 5min. at room temperature. Then 
solutions are put on ice. 
Mixture of;  
 Vector+fragment(µl) Negative control(µl) 
DNA Fragment 6 - 
DNA Vector 1.5 1.5 
2x Ligation Buffer 10 10 
DNA Ligase 1 1 
H2O 1.5 7.5 
Total 20 20 
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Appendix XIII 
Transformation into DH5α Cells 
 
1. Add 100µl of competent cells to each tube. 
2. Add 10µl of ligation mixture. 
3. Mix gently and incubate at 0C for 30 min or longer. 
4. Heat shock the transformation mixture by incubating at 42C for 45 sec., place on ice 
for 1 min. 
5. Add 250µl SOC medium/LB to each tube. 
6. Incubate at 37C for 45-120 min. depending on the selective marker. 
7. Spread on plates and incubate overnight. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
Appendix XIV 
Sequence Reaction 
 
Mix the following in a PCR tube: 
Terminator ‘Ready Reaction’ Mix                4µl 
Sequencing Primer (1.6pmol/µl)                1µl 
Template DNA+H2O  5µl  (0.5µl template +4µl H2O) 
Total Volume              10µl 
 
Mix well and use program as; 
1 cycle of 96°C 1min, 
25 cycles of (96°C for 30sec. + 50°C for 15 sec. + 60°C for 4 min.) 
Hold at 4°C 
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Appendix XV 
Purification of Sequence Reaction 
 
1. Add 40µl 75/25 % isopropanol/water. Close the tubes and vortex briefly. Leave the 
tubes on the bench for 15min. Shorter time may lead to loss of short extension 
products, longer time (>24 hours) may lead to recovery of unincorporated dye 
terminators. 
2. Place the tubes in the microcentrifuge, hinge outside, and spin at maximal speed for 
30 min. 
3. Immediately, and very carefully,discard all the liquid. The pellet may not be visible.  
You know however that is located under the hinge. 
4. Wash briefly: add 125µl 75/25 % isopropanol/water, spin 15min., hinge outside, and 
remove all liquid. Dry the pellet in the thermal cycler with open lid for 4 min. at 90C. 
The samples are stored at -20C until electrophoresis. 
5. Right before samples are to be applied to sequencer, add 15µl Hi Di Formamide, 
vortex the sample and spin down the liquid. 
6. Denature the sample at 95C for 2min., chill on ice, and spin down liquid again. 
7. Transfer samples to sequencing tubes. Keep the samples on ice (or at -20C) until they 
are loaded onto the sequencing machine. 
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Appendix XVI 
Phase 1: Synthesis of Prey Protein 
 
1. Thaw the required number of tubes of TNT T7 Quick Master Mix on ice and/or by hand-
warming, then put on ice. Note: each tube contains 200 µl.  
2. Wear gloves to prevent contamination with RNAses on your hands. Put 40 µl Quick 
Master Mix into eppendorf tubes on ice. Put unused 40 µl aliquots or remaining amount 
of Quick Master Mix back to -70oC (should not be freeze-thawed more than twice).  
3. Thaw nuclease-free water, methionine and plasmid DNA at room temperature, mix 
gently and put on ice. Assemble reactions on ice. Nuclease-free water can be stored at 
4oC after use. 
 
4. Incubate the reactions at 30oC for 90 minutes.  
5. Remove 3 µl from each tube to new eppendorf tubes, which will be run on a SDS-PAGE 
gel then transferred to a membrane and Western-blotted with an antibody to the HA-
epitope, to check that the right proteins have been made from the plasmid DNA. Store 
the 3 µl aliquots at -20oC until you are ready to run the gel.  
 
6. Store the rest of the samples at -70oC until you are ready for Phase 3: Pull-down assay. 
 1 2 3 4 5 6 
Quick 
Master Mix 
40 µl 40 µl 40 µl 40 µl 40 µl 40 µl 
Methionine 1 µl 1 µl 1 µl 1 µl 1 µl 1 µl 
Plasmid 
DNA 
4 µl  
pcDNA6-
HA2 (1-
3)µ 
4 µl  
MCRS1 
4 µl  
pcDNA6-
HA2-Y2 (3-
34)µ 
4 µl  
API5-
N293  
4 µl 
API5-
C369 
4 µl  
API5-
C400 
Nuclease-
free water 
5 µl 5 µl 5 µl 5 µl 5 µl 5 µl 
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Appendix XVII 
Phase 2: Immobilization of GST Proteins 
 
1. Always store the magnetic beads with and without bound proteins at 4oC.  
2. Thaw the required amount of bacterial lysate (see step 10) and keep on ice. 
Equilibration of magnetic beads 
3. Thoroughly resuspend the MagneGST Particles by inverting the bottle several times. 
4. Pipette 40 µl of MagneGST Particles into 2 eppendorf tubes at room temperature. 
5. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
6. Carefully remove and discard the supernatents. 
7. Remove the tubes from the magnetic stand. Add 500 µl of MagneGST Binding/Wash 
buffer to the magnetic beads and resuspend by tapping or inverting tubes. 
8. Repeat steps 5-7 two more times for a total of three washes. 
Binding 
9. After the final wash, resuspend the magnetic beads in 200 µl of MagneGST Binding/Wash 
buffer. 
10. Add bacterial lysate and/or lysis reagent to each tube with resuspended magnetic beads 
as follows: 
 1 2 
Magnetic beads Ca. 200 µl Ca. 200 µl 
GST bacterial lysate (6h) 20 µl  
MagneGST Cell Lysis Reagent 380 µl  
GST-NDRG2 bacterial lysate 
(6h) 
 1 ml 
 
11. Incubate with constant gentle mixing for 30 minutes at room temperature on a rotating 
platform. 
48 
 
Washing 
12. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
13. Carefully remove and discard the supernatents. 
14. Remove the tubes from the magnetic stand. Add 500 µl of MagneGST Binding/Wash 
buffer to the magnetic beads. Incubate at room temperature for 5 minutes while mixing 
occasionally by tapping  or inverting tubes. 
15. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
16. Carefully remove and discard the supernatents. 
17. Remove the tubes from the magnetic stand. Add 500 µl of MagneGST Binding/Wash 
buffer to the magnetic beads. Mix gently by tapping  or inverting tubes. 
18. Repeat steps 15-17 once for a total of three washes. 
19. After the final wash, resuspend the magnetic beads in 40 µl of MagneGST Binding/Wash 
buffer. 
20. Remove 3 µl from each tube to new eppendorf tubes, which will be run on a SDS-PAGE 
gel then transferred to a membrane and Western-blotted with an antibody to the GST-
epitope, to check that the GST proteins have been captured by the magnetic beads. 
Store the 3 µl aliquots at 4oC until you are ready to run the gel.  
 
21. Store the rest of the samples at 4oC until you are ready for Phase 3: Pull-down assay. 
 
 
 
 
 
 
Appendix XVIII 
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Phase 3: Pull-Down assay 
 
Capture of prey protein 
1. Resuspend the GST-or GST-NDRG2-magnetic beads from phase 2 by gently tapping tubes. 
2. Add the following to ependorf tubes: 
 1 2 3 4 5 6 7 8 
GST-beads 
(phase 2) 
5µl 5µl 5µl 5µl     
GST-NDRG2-
beads  
(phase 2) 
    5µl 5µl 5µl 5µl 
MagneGST 
Binding/wash 
buffer 
180µl 180µl 180µl 180µl 180µl 180µl 180µl 180µl 
TNT reaction 
(phase 1) 
15µl 
MCRS1 
15µl 
pcDNA6-
HA2-
Y2(API5) 
15µl 
API5-
N293 
15µl 
API5-
C369 
15µl 
MCSR1 
15µl 
pcDNA6-
HA2-
Y2(API5) 
15µl 
API5-
N293 
15µl 
API5-
C369 
 
3. Incubate with constant gentle mixing for 1 hour at room temperature on a rotating 
platform. 
Washing 
4. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
5. Carefully remove and discard the supernatants. 
6. Remove the tubes from the magnetic stand. Add 400µl of MagneGST Binding/Wash buffer 
to the magnetic beads. Incubate at room temperature for 5 minutes while mixing 
occasionally by tapping or inverting tubes. 
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7. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
8. Carefully remove and discard the supernatants. 
9. Remove the tubes from the magnetic stand. Add 400µl of MagneGST Binding/Wash buffer 
to the magnetic beads. Mix gently by tapping or inverting tubes. 
10. Place the tubes in the magnetic stand and allow a few seconds for magnetic beads to be 
captured by the magnet. 
11. Carefully remove and discard the supernatants. 
12. Repeat steps 9-11 once for a total of three washes. 
Elution 
13 After the final wash, resuspend the magnetic beads in 20µl of 1x SDS loading buffer. 
14. Incubate at room temperature for 5 minutes with mixing. 
15. Place the tubes in the magnetic stand and allow a few seconds for the magnetic beads to 
be captured by the magnet. 
16. Carefully remove the supernatant and transfer to a new eppendorf tubes. Freeze 
samples until you are ready to run the gel. 
17. Denature the samples by heating as normal and load 10 µl on a SDS-PAGE gel. Transfer to 
a membrane and Western-blot with a mouse antibody to the HA-epitope. Save rest of 
samples at 200C. 
 
  
 
 
